Global 1,4,7,10-Tetraazacyclododecane (Cyclen) Market Outlook 2017-2022

July 2017 | 112 pages | ID: GEEB18BFA6BEN
Gen Consulting Company

Abstracts

Cyclen or 1,4,7,10-tetraazacyclododecane is a macrocycle and the aza analogue of the crown ether 12-crown-4. Derivatives of cyclen are larger cyclic polyamines but the repeating unit (ethyleneimine, –CH2CH2NH–) is always the same. Like crown ethers, cyclen compounds are capable of selectively binding cations. They are used as a ligand in chemistry for instance with chemicals used in MRI contrast agents.

The report covers forecast and analysis for the cyclen market on a global and regional level. The study provides historic data of 2012-2016 along with a forecast from 2017 to 2022 based on both volumes and revenue. The study includes drivers and restraints for the cyclen market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cyclen market on a global level.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global cyclen market collected from specialized sources. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. Company overview, financial overview, product portfolio, new project launched, recent development analysis are the parameters included in the profile.

The study provides a decisive view on the cyclen market by segmenting the market based on applications. All the application segments have been analyzed based on present and future trends and the market is estimated from 2017 to 2022.Key Applications

• MRI Contrast Agents
• ProHance
• Gadavist
• Dotarem
• Others

Key Regions

• North America
• Europe
• Asia Pacific

Key Vendors

• Guerbet
• Bayer Vital
• Bracco
• Bolon
• Hubei Tianshu
• Heryi Pharma
• Taicang Qianjing
• Chem Stone
• Nanhua
• Xiamen Huasing

Key Questions Answered in this Report

• What will the market size be in 2022?
• What are the key factors driving the global cyclen market?
• What are the challenges to market growth?
• Who are the key players in the cyclen market?
• What are the market opportunities and threats faced by the key players?

Contents

PART 1. EXCLUSIVE SUMMARY

PART 2. METHODOLOGY

2.1 Research Methodology
2.2 Geographic Scope
2.3 Years Considered

PART 3. INTRODUCTION

3.1 Product Overview
3.2 Applications of Cyclen
3.3 Manufacturing Process
3.4 Raw Materials
3.5 Cost Analysis

PART 4. COMPETITIVE LANDSCAPE

4.1 Global Cyclen Market, by Volume 2012-2017
  4.1.1 Overview
  4.1.2 Global Cyclen Market, by Volume, by Company
  4.1.3 Top 3 Companies by Volume Share
4.2 Global Cyclen Market, by Revenue 2012-2017
  4.2.1 Overview
  4.2.2 Global Cyclen Market, by Revenue, by Company
  4.2.3 Top 3 Companies by Revenue Share

PART 5. MARKET DYNAMICS

5.1 Market Drivers
5.2 Challenges
5.3 Market Trends

PART 6. SEGMENTATION BY APPLICATION

6.1 Overview
6.2 ProHance Market
6.3 Gadavist Market
6.4 Dotarem Market

PART 7. NORTH AMERICA

7.1 North American Cyclen Market Size
7.2 by Country
  7.2.1 United States
  7.2.2 Canada

PART 8. EUROPE

8.1 European Cyclen Market Size
8.2 by Country
  8.2.1 Germany
  8.2.2 UK
  8.2.3 France

PART 9. ASIA-PACIFIC

9.1 Asia-Pacific Cyclen Market Size
9.2 by Country
  9.2.1 China
  9.2.2 Japan
  9.2.3 India

PART 10. CYCLEN MARKET FORECAST

10.1 Global Cyclen Market Size 2017-2022
10.2 Global Cyclen Market by Region 2017-2022
  10.2.1 North America
  10.2.2 Europe
  10.2.3 Asia-Pacific
10.4 Global Cyclen Market by Application 2017-2022

PART 11. COMPANY PROFILES

11.1 Guerbet
  11.1.1 Business Overview
  11.1.2 Products Offered
  11.1.3 Financials
11.2 Bayer Vital
11.3 Bracco
11.4 Bolon
11.5 Hubei Tianshu
11.6 Heryi Pharma
11.7 Taicang Qianjing
11.8 Chem Stone
11.9 Nanhua
11.10 Xiamen Huasing

...

PART 12. APPENDIX

12.1 Abbreviations
12.2 Disclaimer